Medtelligence: Linking Science to Clinical Practice - Medtelligence

Medtelligence Hero

Linking Science
to Clinical Practice

Innovative, high-quality medical education for clinicians in cardiology and other specialties.

Featured

Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
CME/CE
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD; Maurizio Gallieni, MD
0.25 credits
- Steven Fishbane, MD
- Maurizio Gallieni, MD
0.25 credits
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
CME/CE
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Chee Kay Cheung, MBChB, MRCP, PhD; Claudia Seikrit, MD
0.25 credits
- Chee Kay Cheung, MBChB, MRCP, PhD
- Claudia Seikrit, MD
0.25 credits
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
CME/CE
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA; Nihar R. Desai, MD, MPH
0.25 credits
- Ellie Kelepouris, MD, FACP, FAHA
- Nihar R. Desai, MD, MPH
0.25 credits
MinuteCE®
The Potassium Shift: Individualizing Hyperkalemia Management With Modern Oral Potassium Binders
James Burton, DM, FRCP; Nihar R. Desai, MD, MPH
1.00 credit 8 episodes
- James Burton, DM, FRCP
- Nihar R. Desai, MD, MPH
- Ellie Kelepouris, MD, FACP, FAHA
- Pauline A. Swift, PhD
1.00 credit 8 episodes

Popular

The Unmet Need in ASCVD: Why Targets Are Still Not Enough
The Unmet Need in ASCVD: Why Targets Are Still Not Enough
MinuteCE®
The Unmet Need in ASCVD: Why Targets Are Still Not Enough
Erin Michos
1.00 program credit
- Erin Michos
1.00 program credit
Obicetrapib: Mechanism Meets Clinical Impact
Obicetrapib: Mechanism Meets Clinical Impact
MinuteCE®
Obicetrapib: Mechanism Meets Clinical Impact
Christie Ballantyne, MD
1.00 program credit
- Christie Ballantyne, MD
1.00 program credit
Beyond Lipids: Metabolic and Renal Implications of CETP Inhibition
Beyond Lipids: Metabolic and Renal Implications of CETP Inhibition
MinuteCE®
Beyond Lipids: Metabolic and Renal Implications of CETP Inhibition
Erin Michos
1.00 program credit
- Erin Michos
1.00 program credit
Lipids and the Brain: Extending Cardiovascular Risk Reduction to Neurodegenerative Disease
Lipids and the Brain: Extending Cardiovascular Risk Reduction to Neurodegenerative Disease
MinuteCE®
Lipids and the Brain: Extending Cardiovascular Risk Reduction to Neurodegenerative Disease
Christie Ballantyne, MD; Philip Scheltens, MD, PhD
1.00 program credit
- Christie Ballantyne, MD
- Philip Scheltens, MD, PhD
1.00 program credit
Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
MinuteCE®
Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
Ellie Kelepouris, MD, FACP, FAHA
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
1.00 program credit
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
MinuteCE®
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
James Burton, DM, FRCP; Ellie Kelepouris, MD, FACP, FAHA
1.00 program credit
- James Burton, DM, FRCP
- Ellie Kelepouris, MD, FACP, FAHA
1.00 program credit
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
MinuteCE®
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
Ellie Kelepouris, MD, FACP, FAHA; Pauline A. Swift, PhD
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
- Pauline A. Swift, PhD
1.00 program credit
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
MinuteCE®
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
James Burton, DM, FRCP; Nihar R. Desai, MD, MPH
1.00 program credit
- James Burton, DM, FRCP
- Nihar R. Desai, MD, MPH
1.00 program credit